Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump’s win on the Indian pharmaceutical sector. Growing demand for affordable medicines, and diversification from China are key factors benefitting his company. He also talks about R&D and productivity as drivers to further increase margins.